Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Psyched Wellness says preliminary study data indicates its proprietary extract AME-1 holds anti-inflammatory properties

The study with the National Research Council of Canada is using the Amanita Muscaria mushroom by examining its effects on mast cells, which are important inflammatory cells present in the skin, gut, brain, and lungs

Psyched Wellness Ltd. has announced that preliminary data from its study with the National Research Council of Canada (NRC) indicates that AME-1, the company's key proprietary extract, holds anti-inflammatory properties.

The study is examining the anti-inflammatory properties of the AME-1 extract from the Amanita Muscaria mushroom by studying the effects of the extract on mast cells, which are important inflammatory cells present in the skin, gut, brain, and lungs.

Prior research performed by the NRC had already shown that AME-1 inhibited mast cell activation of histamine release.

READ: Psyched Wellness partners with Vantage Hemp for manufacturing its AME-1-derived consumer products

In a statement, Psyched Wellness said the continued research has verified that pre-treatment of human mast cells with AME-1 results in the decrease of the release of pro-inflammatory mediators such as inflammatory cytokines.

"The preliminary evidence of the study reveals key nutritional systematic and functional properties of the AME-1 extract that may have the potential to provide anti-inflammatory health and wellness benefits," said Brian Tancowny, scientific advisor to Psyched Wellness (CSE:PSYC, OTCQB:PSYCF). "We will continue to investigate and seek to further understand the properties of the Amanita Muscaria mushroom and its anti-inflammatory properties."

Psyched Wellness (CSE:PSYC, OTCQB:PSYCF) CEO Jeff Stevens added: "The anti-inflammatory properties and potential benefits of AME-1 as a natural product in reducing chronic inflammation are unique and novel. We are excited about these findings and the potential they may have to help sufferers of conditions such as arthritis.”

The NRC is an agency of the Government of Canada which specializes in providing vital scientific and technological services to the research and industrial communities of Canada.

Psyched Wellness (CSE:PSYC, OTCQB:PSYCF) said it engaged the NRC to provide its expertise in biomedical nanotechnology for the study, but all the results of the research will belong to the company, and the NRC does not endorse the findings nor Psyched Wellness products.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK